Currently, proton pump inhibitors are used in a wide range of patients with gastroesophageal reflux disease, peptic ulcer, and upper gastrointestinal symptoms such as dyspepsia. In addition, the application of proton pump inhibitors for prevention of gastrointestinal complications induced by non-steroidal anti-inflammatory drugs is expected to increase their use in the future. The use of proton pump inhibitors promotes bacterial growth by reducing gastric acid concentration. If the acidity (pH) of the stomach fluid is lower than 4, most pathogens can be sterilized. However, patients who need to use a proton pump inhibitor should maintain a gastric acidity of at least 5 or 6, and can be at risk of infections such as pneumonia and Clostridium...
Inhibition of the H+/K+-adenosine triphosphatase (the proton pump) is the final common mechanistic p...
Introduction: The introduction of proton pump inhibitors (PPIs) into clinical practice has greatly i...
<p>Proton Pump Inhibitor (PPI) use and the risk of <i>Salmonella</i>-, <i>Campylobacter</i>-, and <i...
BACKGROUND: Proton pump inhibitors (PPIs) have become the mainstay of treatment for and prevention o...
Abstract Background Proton pump inhibitors (PPIs) are the most efficacious and common medications fo...
Proton pump inhibitors (PPI) are very effective drugs used largely in acid related disorders. During...
Proton pump inhibitors (PPIs) suppress gastric acid secretion by selectively inhibiting the enzyme h...
textabstractAn association between proton pump inhibitor (PPI) therapy and bacterial gastroenteritis...
Increased incidence of Clostridium difficile infection (CDI) among in-patients is associated with si...
Proton pump inhibitors have changed the management of acid-related upper gastrointestinal disorders....
Acid-related disorders of the upper gastrointestinal tract are the most important indications for tr...
Background: Proton pump inhibitors are among the most frequently prescribed drugs in the world and a...
The advent of powerful acid-suppressive drugs, such as proton pump inhibitors (PPIs), has revolution...
Abstract The introduction of proton-pump inhibitors (PPIs) into clinical practice since about thi...
Introduction: To quantify the association between PPI use, type and dose and infectious gastroenteri...
Inhibition of the H+/K+-adenosine triphosphatase (the proton pump) is the final common mechanistic p...
Introduction: The introduction of proton pump inhibitors (PPIs) into clinical practice has greatly i...
<p>Proton Pump Inhibitor (PPI) use and the risk of <i>Salmonella</i>-, <i>Campylobacter</i>-, and <i...
BACKGROUND: Proton pump inhibitors (PPIs) have become the mainstay of treatment for and prevention o...
Abstract Background Proton pump inhibitors (PPIs) are the most efficacious and common medications fo...
Proton pump inhibitors (PPI) are very effective drugs used largely in acid related disorders. During...
Proton pump inhibitors (PPIs) suppress gastric acid secretion by selectively inhibiting the enzyme h...
textabstractAn association between proton pump inhibitor (PPI) therapy and bacterial gastroenteritis...
Increased incidence of Clostridium difficile infection (CDI) among in-patients is associated with si...
Proton pump inhibitors have changed the management of acid-related upper gastrointestinal disorders....
Acid-related disorders of the upper gastrointestinal tract are the most important indications for tr...
Background: Proton pump inhibitors are among the most frequently prescribed drugs in the world and a...
The advent of powerful acid-suppressive drugs, such as proton pump inhibitors (PPIs), has revolution...
Abstract The introduction of proton-pump inhibitors (PPIs) into clinical practice since about thi...
Introduction: To quantify the association between PPI use, type and dose and infectious gastroenteri...
Inhibition of the H+/K+-adenosine triphosphatase (the proton pump) is the final common mechanistic p...
Introduction: The introduction of proton pump inhibitors (PPIs) into clinical practice has greatly i...
<p>Proton Pump Inhibitor (PPI) use and the risk of <i>Salmonella</i>-, <i>Campylobacter</i>-, and <i...